Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-administered Lidocaine Gel for IUD Pain
NCT02943135Phase 3Completed
- Sponsor
- Assiut University
- Start
- Oct 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in procedural pain (2 arms), sponsored by Assiut University. Primary endpoint: Mean pain score during intrauterine device insertion. Started Oct 2017; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02943135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943135.